Inhibition of p38 kinase activity using substituted...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 261/14 (2006.01) A61K 31/381 (2006.01) A61K 31/415 (2006.01) A61K 31/42 (2006.01) A61K 31/426 (2006.01) A61K 31/4439 (2006.01) C07D 231/40 (2006.01) C07D 277/48 (2006.01) C07D 333/36 (2006.01)

Patent

CA 2315720

This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases, other than cancer and proteolytic enzyme mediated diseases, other than cancer, and pharmaceutical compositions for use in such therapy.

L'invention a trait à l'utilisation d'un groupe d'aryle urées pour traiter des maladies, autres que le cancer, induites par des cytokines, et des maladies, autres que le cancer, induites par des enzymes protéolytiques; et à des compositions utiles pour ce type de thérapie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhibition of p38 kinase activity using substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of p38 kinase activity using substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of p38 kinase activity using substituted... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1708745

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.